Dear Colleagues, We are pleased to announce the official opening of registration and abstract submissions (posters and oral presentations) for the joint congress of three SFBBM Thematic Groups : Enzymes, Proteolysis & Metabolism at the Crossroads of Biochemistry📅 3–5 December 2025Paris – Auditorium Buffon, Université Paris Cité (13ᵗʰ district)🌐 Conference website: https://gts-sfbbm-2025.sciencesconf.org
Congratulations to our doctoral students, Enzo Vidy, Katia Montero-Diaz, and postdoctoral researcher Bhupinder Kaur, for their excellent presentations at the PEPR Biotherapies and Bioproduction of Innovative Therapies conference in Montpellier! A wonderful showcase of the advances being made at CEPR. #France2030 #PEPR #Biotherapies #Bioproduction
Brilliant presentation of Margaux’s PhD work at the 20th edition of the Microbes Congress, organized by the Société Française de Microbiologie! She had the opportunity to present part of my PhD work on post-influenza aspergillosis superinfections, and to exchange with an outstanding community of researchers, clinicians, and fellow students. 🦠🍄
Guillaume was appointed president by the general assembly of the French Society of Medical Mycology (SFMM) for the next four years.
😊 Excited to share our latest publication in European Journal of Pharmaceutics and Biopharmaceutics on the impact of biological barriers on inhaled antibodies! 👏 This work is the result of a highly productive, collaborative, and enjoyable partnership with CSL Behring. A special thank you to @ and the entire team for their great contributions! 👉 doi.org/10.1016/j.ejpb.2025.114817
A relaxation day at the CEPR !!Bowling and billiards are on the agenda for this summer event ! A wonderful day to conclude a rich and dynamic academic year for our laboratory.
👏 Very proud of the CEPR INSERM Lab PhD students!! Oral presentation and posters for the Centre-Val de Loire Region PhD Day. 😀 Congratulations, you are flying the flag for your laboratory! University of Tours – Inserm
We are presenting a concise overview of the existing rationale and evidence and provide guidance for implementing inhaled antibiotics among ventilated critically ill patients, published in the American Journal of Respiratory and Critical Care Medicine.
The Team 3 (Virginie Hervé, Sandrine Le Guellec & Mike Pasteur) was recently on air during La Méridienne, the daily radio show on Radio Campus Tours 99.5 FM! We had a very enjoyable time sharing our work with Melissa Wyckhuyse, as we discussed the different in vitro models developed in our lab for the advancement of new inhaled therapies. 👏 Many thanks to Melissa Wyckhuyse, Pierre DaSilva (Ph.D.), and Jean-Michel Escoffre, Ph.D., for organizing this inspiring edition of Les Méridiennes! 🎧 You can listen to the full episode of the show via the podcast by clicking >Here<
The PEPR 2024 project is coordinated by Mathieu Epardaud (ISP – INRAe/University of Tours) and Thomas Sécher (CEPR – Team 3 – Inserm/University of Tours). 🔬- InHEALation – aims to develop an innovative prophylactic and therapeutic inhaled platform against respiratory viruses.